126 - Paul Diaz, President & CEO of Myriad Genetics, on applying the power of data-driven genetic insights

A Second Opinion with Senator Bill Frist, M.D.

内容由Bill Frist and A Second Opinion Podcast提供。所有播客内容（包括剧集、图形和播客描述）均由 Bill Frist and A Second Opinion Podcast 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

3y ago 41:49

MP3•单集首页

已归档的系列专辑 ("不活跃的收取点" status)

When? This feed was archived on August 02, 2023 17:10 (9M ago). Last successful fetch was on June 27, 2023 13:36 (10M ago)

Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间，但仍然无法截取有效的播客收取点

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Paul Diaz is President & CEO of Myriad Genetics. Thirty years ago, Myriad Genetics played a pivotal role in one of the most important breakthroughs in the history of healthcare: discovering the precise location and sequence of the BRCA1 and BRCA2 genes, which increase the risk of breast cancer. This led to the emergence of genetic testing as a tool that has saved millions of lives. Now, with Paul at the helm, Myriad Genetics aims to play as pivotal a role in the next 30 years of genetics and precision medicine as they did in the first 30, applying the power of data-driven genetic insights. You’ll want to hear how Paul and Myriad are empowering patients and physicians to better detect, treat, and prevent disease.

To learn more about the work Paul and Myriad Genetics are doing to lead the way on genetic testing and precision medicine, read Paul’s latest blog post: https://myriad.com/health-illuminated/

201集单集

#Fitness #Government #Billfrist #Healthcare #Innovation #Medicine #Policy #Technology #Frist #Second Opinion #COVID19 #Health and Well-Being #Senate